The opportunity
Territory : Southwest, including Colorado, Arizona, New Mexico
What you'll do
Develop and execute strategic territory business plans to drive Signatera: adoption, achieve sales objectives, and maximize market opportunities.
Build and strengthen relationships with Urologic Oncologists, GU Surgical: Oncologists, Medical Oncologists, Radiation Oncologists, Pathologists, and other key stakeholders across the GU Oncology continuum of care.
Drive new account acquisition, expand existing partnerships, and identify: growth opportunities within academic medical centers, hospital systems, leading urology practices, and community oncology networks.
Educate healthcare providers on Signatera's clinical applications, supporting: evidence, and value in the management of GU cancers, including bladder, kidney, and testicular cancers.
Develop relationships with Key Opinion Leaders (KOLs) specializing in GU: Oncology, particularly within major academic medical centers and leading urology and oncology practices.
Establish expertise in Natera's molecular diagnostics technology, clinical: evidence, product offerings, and competitive landscape.
What they're looking for
- Collaborate closely with Natera's Core Oncology Sales team and: cross-functional partners to align account strategies and maximize commercial effectiveness.
- Identify opportunities to expand Signatera adoption through physician: education, strategic account development, and multidisciplinary care team engagement.
- Navigate complex healthcare systems, reimbursement processes, and: institutional requirements to support successful product adoption.
- Partner with internal teams to resolve operational challenges, support: account needs, and ensure a positive customer experience.
